Advertisement

Topics

Mirna Therapeutics Inc. Company Profile

12:01 EDT 24th September 2017 | BioPortfolio

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending intellectual property around miRNAs developed by its own scientists as well as in-licensed from other institutions. Mirna’s IP portfolio contains >300 miRNAs with applications in oncology and other diseases. Oncology-directed miRNAs include those that are key tumor suppressors in cancer, such as miR-34 and let-7 that have proven to block tumor growth in a number of different pre-clinical animal studies. The Company, founded in 2007, is located in Austin, Texas. For more information, visit www.mirnarx.com.


News Articles [1576 Associated News Articles listed on BioPortfolio]

Synlogic and Mirna Therapeutics to merge

Privately held Synlogic has entered into a definitive merger agreement with Mirna Therapeutics under which Synlogic will merge with a wholly owned subsidiary of Mirna in an all-stock transaction. The ...

Synlogic takeover secures Mirna’s NASDAQ listing + $40m cash

Synlogic has announced it will conduct a reverse merger with failed Mirna Therapeutics, to focus on metabolic and inflammatory diseases and cancer.

Mirna, Synlogic reverse merge in stock swap

Closely held Synlogic Inc. is reverse merging with publicly traded Mirna Therapeutics Inc.

Synlogic, Mirna Agree to Stock-Based Merger to Focus on Synthetic Biotic Pipeline

Synlogic and Mirna Therapeutics inked a definitive stock-based merger agreement to form a combined entity that will develop Synlogic’s engineered microbiome-based Synthetic Biotic platform and pipel...

miRNA Tools and Services Market by Product [Research Tools Kits, Reagents, and Other Consumables and Services miRNA Extraction Services, Quantification Services, Microarray Services, Sequencing Services, Functional Studies Services, and Others], Technolog

miRNA is a set of small, noncoding RNA molecules that regulate gene expression post transcription. These molecules have an impact on a wide range of biological functions such as cell cycle control, st...

Using miRNA to cure mature B cell neoplasia

Almost half of patients with mature B cell neoplasia are faced with the ineffectiveness of existing treatments. However, they may soon benefit from new therapeutic tools relying on miRNA—a small non...

NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing

The lncRNA NEAT1, a key component of paraspeckles, interacts with RNA-binding proteins, including NONO and PSF, and affects global pri-miRNA processing by recruiting the Drosha–DGCR8 Microprocessor.

Development of RNAi-based anti-cancer therapeutics

Understanding the interactions between miRNAs with their specific cancer gene targets is an on-going effort to identify new therapeutic strategies. Researchers from University of Malaya carried out in...

PubMed Articles [1019 Associated PubMed Articles listed on BioPortfolio]

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine.

In the past few years, therapeutic microRNA (miRNA) and small interfering RNA (siRNA) are some of the most important biopharmaceuticals that are in commercial space as future medicines. This review su...

MicroRNAs in injury and repair.

Organ damage and resulting pathologies often involve multiple deregulated pathways. MicroRNAs (miRNAs) are short, non-coding RNAs that regulate a multitude of genes at the post-transcriptional level. ...

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR.

MicroRNAs (miRNAs) are small noncoding RNAs that regulate messenger RNA expression post-transcriptionally. The miRNA expression profile has been investigated in various organs and tissues in rat. Howe...

The Diagnostic Value of Serum miRNA-221-3p, miRNA-382-5p, and miRNA-4271 in Ischemic Stroke: Methodological Issue to Avoid Misinterpretation.

Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.

Multiple myeloma (MM) is a heterogeneous disorder, encompassing several related entities that share the common characteristic of being composed of monoclonal plasma cells (PCs). MicroRNAs (miRNAs) are...

Clinical Trials [163 Associated Clinical Trials listed on BioPortfolio]

microRNA Expression in Renal Cell Carcinoma

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look fo...

Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study

In the present project we propose a large prospective study in heavy smokers volunteers based on plasma miRNA profiling to assess its efficacy as a first line screening test for lung cance...

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

MicroRNAs (miRNA) are molecular biomarkers that post-transcriptionally control target genes. Deregulated miRNA expression has been observed in diverse cancers. In high grade gliomas, know...

microRNAs Tool for Stratifying Stage II Colon Cancer

The investigators discover the investigators' miRNA tool can be a useful tool to predict the patients with stage II colon who can benefit from chemotherapy.Then the investigators plan to m...

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients

Objectives: The aim of the present study is to assess the significance of metabolomics and genetics in diagnosing and survival evaluation for pNET in the periodic follow-up of MEN1 patien...

Companies [1161 Associated Companies listed on BioPortfolio]

Mirna Therapeutics Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending i...

Mirna Therapeutics, Inc. and Horizon Discovery Ltd.

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company focused on the development and commercialization of miRNA therapeutics. The Company has a foundational intellectual pro...

Mirna Therapeutics

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company founded in late 2007 as a spin-off from Asuragen Inc. and is located in Austin, Texas. Mirna is focused on the developm...

Mirna Therapeutics, Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending inte...

Synlogic, Inc. and Mirna Therapeutics, Inc.

More Information about "Mirna Therapeutics Inc." on BioPortfolio

We have published hundreds of Mirna Therapeutics Inc. news stories on BioPortfolio along with dozens of Mirna Therapeutics Inc. Clinical Trials and PubMed Articles about Mirna Therapeutics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mirna Therapeutics Inc. Companies in our database. You can also find out about relevant Mirna Therapeutics Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record